Matches in SemOpenAlex for { <https://semopenalex.org/work/W2955282851> ?p ?o ?g. }
- W2955282851 endingPage "3759" @default.
- W2955282851 startingPage "3745" @default.
- W2955282851 abstract "// Parmanand Malvi 1 , Biao Wang 1 , Shreni Shah 1 and Romi Gupta 1 , 2 1 Department of Pathology, Yale University School of Medicine, New Haven, CT, 06510, USA 2 Department of Biochemistry and Molecular Genetics, University of Alabama at Birmingham, Birmingham, AL, 35233, USA Correspondence to: Romi Gupta, email: romigup@uab.edu Keywords: RNA modifications; epitranscriptome; melanoma; MAPK; BRAF mutant melanoma Received: November 08, 2018 Accepted: April 29, 2019 Published: June 04, 2019 ABSTRACT Melanoma is the deadliest form of skin cancer. Despite recent advances in medicine and the development of new treatments for melanoma, cures remain elusive as acquired resistance to both targeted and immunotherapies are becoming common. Therefore, more studies are conducted to dissect underlying molecular mechanisms that drive melanoma growth in order to provide better therapeutic option. Here, employing a comprehensive and unbiased analysis of different RNA modification regulatory proteins using various publicly available databases we identify the most relevant RNA modifying proteins that plays crucial role in melanoma development. Our study started with the analysis of various genetic alterations (amplifications, mutations/deletion) as well as RNA overexpression of these RNA modification regulatory proteins in The Cancer Genome Atlas melanoma database. We then analyzed their expression in The Human Protein Atlas data. The result of analysis revealed that only a subset of RNA modification regulatory proteins are overexpressed in >75% of melanoma patient cases as compared to normal skin. However, when examined in Oncomine dataset we found only two genes (METTL4 and DNMT3A) were significantly overexpressed in melanoma samples versus normal skin samples and matched with the results of The Human Protein Atlas data. Therefore, we functionally validated METTL4 and DNMT3A using shRNA-mediated knockdown and found that their knockdown in melanoma cells led to melanoma cells growth inhibition. Collectively, in this study, we investigated the epitranscriptomic landscape of melanoma using various publicly available database and identified DNMT3A and METTL4 as the most relevant potential regulators of melanoma growth." @default.
- W2955282851 created "2019-07-12" @default.
- W2955282851 creator A5034724363 @default.
- W2955282851 creator A5059801211 @default.
- W2955282851 creator A5071271357 @default.
- W2955282851 creator A5075523709 @default.
- W2955282851 date "2019-06-04" @default.
- W2955282851 modified "2023-10-17" @default.
- W2955282851 title "Dissecting the role of RNA modification regulatory proteins in melanoma" @default.
- W2955282851 cites W112133451 @default.
- W2955282851 cites W1590876544 @default.
- W2955282851 cites W1933156045 @default.
- W2955282851 cites W1950829641 @default.
- W2955282851 cites W1972721128 @default.
- W2955282851 cites W1977918192 @default.
- W2955282851 cites W2007429249 @default.
- W2955282851 cites W2013733230 @default.
- W2955282851 cites W2015009944 @default.
- W2955282851 cites W2017128352 @default.
- W2955282851 cites W2025429390 @default.
- W2955282851 cites W2032211985 @default.
- W2955282851 cites W2034564573 @default.
- W2955282851 cites W2035000040 @default.
- W2955282851 cites W2041129610 @default.
- W2955282851 cites W2055708350 @default.
- W2955282851 cites W2057113047 @default.
- W2955282851 cites W2060573548 @default.
- W2955282851 cites W2065847836 @default.
- W2955282851 cites W2078964320 @default.
- W2955282851 cites W2083071223 @default.
- W2955282851 cites W2094525451 @default.
- W2955282851 cites W2096387850 @default.
- W2955282851 cites W2100808905 @default.
- W2955282851 cites W2114103020 @default.
- W2955282851 cites W2117025824 @default.
- W2955282851 cites W2125552027 @default.
- W2955282851 cites W2128542677 @default.
- W2955282851 cites W2134471382 @default.
- W2955282851 cites W2141674733 @default.
- W2955282851 cites W2153105757 @default.
- W2955282851 cites W2158485828 @default.
- W2955282851 cites W2167074775 @default.
- W2955282851 cites W2167616678 @default.
- W2955282851 cites W2167867263 @default.
- W2955282851 cites W2172336833 @default.
- W2955282851 cites W2180404227 @default.
- W2955282851 cites W2203677081 @default.
- W2955282851 cites W2239758289 @default.
- W2955282851 cites W2252643587 @default.
- W2955282851 cites W2271549028 @default.
- W2955282851 cites W2271995006 @default.
- W2955282851 cites W2340746011 @default.
- W2955282851 cites W2397962830 @default.
- W2955282851 cites W2465860350 @default.
- W2955282851 cites W2529373149 @default.
- W2955282851 cites W2545309317 @default.
- W2955282851 cites W2546967042 @default.
- W2955282851 cites W2559344646 @default.
- W2955282851 cites W2567028337 @default.
- W2955282851 cites W2600862208 @default.
- W2955282851 cites W2601926225 @default.
- W2955282851 cites W2606518593 @default.
- W2955282851 cites W2608166870 @default.
- W2955282851 cites W2615796845 @default.
- W2955282851 cites W2627064270 @default.
- W2955282851 cites W2736730167 @default.
- W2955282851 cites W2757254843 @default.
- W2955282851 cites W2766140892 @default.
- W2955282851 cites W2766586377 @default.
- W2955282851 cites W2769856951 @default.
- W2955282851 cites W2783974691 @default.
- W2955282851 cites W2807768256 @default.
- W2955282851 cites W2891942618 @default.
- W2955282851 cites W4244068819 @default.
- W2955282851 doi "https://doi.org/10.18632/oncotarget.26959" @default.
- W2955282851 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/6557201" @default.
- W2955282851 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/31217906" @default.
- W2955282851 hasPublicationYear "2019" @default.
- W2955282851 type Work @default.
- W2955282851 sameAs 2955282851 @default.
- W2955282851 citedByCount "6" @default.
- W2955282851 countsByYear W29552828512020 @default.
- W2955282851 countsByYear W29552828512021 @default.
- W2955282851 countsByYear W29552828512022 @default.
- W2955282851 crossrefType "journal-article" @default.
- W2955282851 hasAuthorship W2955282851A5034724363 @default.
- W2955282851 hasAuthorship W2955282851A5059801211 @default.
- W2955282851 hasAuthorship W2955282851A5071271357 @default.
- W2955282851 hasAuthorship W2955282851A5075523709 @default.
- W2955282851 hasBestOaLocation W29552828511 @default.
- W2955282851 hasConcept C104317684 @default.
- W2955282851 hasConcept C121608353 @default.
- W2955282851 hasConcept C2777658100 @default.
- W2955282851 hasConcept C2777789703 @default.
- W2955282851 hasConcept C502942594 @default.
- W2955282851 hasConcept C54355233 @default.
- W2955282851 hasConcept C60644358 @default.
- W2955282851 hasConcept C67705224 @default.